VULVAR CARCINOMA

This study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…

This phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…

This study follows 72 women with pelvic cancers (like cervical or rectal) to see how radiation therapy changes their pelvic health and sexual function over two years. Researchers measure physical changes and ask about symptoms like dryness or pain. The goal is to better understan…

This study follows 79 women with gynecologic cancers (cervical, endometrial, vaginal, or vulvar) who had a pelvic exenteration—a surgery removing the lower colon, rectum, and bladder. Researchers track complications, quality of life, and cancer recurrence over time to learn which…